Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06715306
NA

Intravenous Versus Oral Treatment of the Main Acute Infections

Sponsor: University of Southern Denmark

View on ClinicalTrials.gov

Summary

Patients admitted to the hospital with acute infections are often treated with intravenous (IV) antibiotics. Around 70% of these infections fall into three categories: respiratory tract infections, urinary tract infections, and cellulitis. A Danish study found that 76% of patients admitted with suspected community-acquired pneumonia and treated with antibiotics received them intravenously. Based on an extrapolated estimate from an unpublished local survey, approximately 50,000 patients in Denmark are admitted each year for infections and treated with IV antibiotics. The average hospital stay for these patients is 5.9 days, resulting in a total of 295,000 hospital days annually, accounting for about 7% of total hospital admissions in Denmark. This represents an annual cost of 2.3 billion DKK. While some patients need hospitalization due to their overall health or other serious conditions, others remain hospitalized primarily to receive IV antibiotics. Expanding the use of oral antibiotics in emergency departments should be pursued only if it can demonstrate comparable efficacy and safety to IV administration. Therefore this study will investigate the efficiency of primarily oral antibiotics in acutely admitted patients with proven or suspected infections. Additionally, the investigators will evaluate the safety of oral regimen for these patients.

Official title: Intravenous Versus Oral Treatment of the Main Acute Infections in Emergency Departments

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

4000

Start Date

2025-01-15

Completion Date

2028-01-06

Last Updated

2026-03-05

Healthy Volunteers

No

Interventions

OTHER

Oral treatment

Patients randomized to oral treatment will commence the oral treatment immediately. The oral treatment is based on specially developed treatment suggestions developed by microbiologists and specialists in infectious diseases from the participating regions, and in respect with local treatment guidelines (detailed described in the protocol).

Locations (7)

Sygehus Sønderjylland

Aabenraa, Southern Denmark, Denmark

Bispebjerg and Frederiksberg Hospital

Copenhagen, Denmark

Nordsjællands Hospital

Copenhagen, Denmark

Esbjerg and Grindsted Sygehus

Esbjerg, Denmark

Herlev and Gentofte Hospital

Herlev, Denmark

Amager and Hvidovre Hospital

Hvidovre, Denmark

Sygehus Lillebælt

Kolding, Denmark